Metabolix Debt to Equity Ratio 2010-2024 | YTEN
Current and historical debt to equity ratio values for Metabolix (YTEN) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Metabolix debt/equity for the three months ending June 30, 2024 was 0.00.
Metabolix Debt/Equity Ratio Historical Data |
Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
2024-06-30 |
$0.01B |
$-0.01B |
-1.48 |
2024-03-31 |
$0.01B |
$-0.00B |
-2.28 |
2023-12-31 |
$0.01B |
$-0.00B |
-2.57 |
2023-09-30 |
$0.01B |
$0.00B |
14.41 |
2023-06-30 |
$0.01B |
$0.00B |
9.00 |
2023-03-31 |
$0.00B |
$0.00B |
3.67 |
2022-12-31 |
$0.00B |
$0.00B |
0.84 |
2022-09-30 |
$0.00B |
$0.01B |
0.56 |
2022-06-30 |
$0.00B |
$0.01B |
0.39 |
2022-03-31 |
$0.00B |
$0.01B |
0.30 |
2021-12-31 |
$0.00B |
$0.02B |
0.27 |
2021-09-30 |
$0.00B |
$0.02B |
0.24 |
2021-06-30 |
$0.01B |
$0.02B |
0.23 |
2021-03-31 |
$0.00B |
$0.02B |
0.19 |
2020-12-31 |
$0.01B |
$0.01B |
0.52 |
2020-09-30 |
$0.01B |
$0.01B |
0.40 |
2020-06-30 |
$0.01B |
$0.01B |
0.58 |
2020-03-31 |
$0.01B |
$0.01B |
0.61 |
2019-12-31 |
$0.02B |
$-0.00B |
-5.09 |
2019-09-30 |
$0.01B |
$0.00B |
2.60 |
2019-06-30 |
$0.01B |
$0.00B |
1.51 |
2019-03-31 |
$0.01B |
$0.01B |
1.11 |
2018-12-31 |
$0.01B |
$0.01B |
1.27 |
2018-09-30 |
$0.00B |
$0.01B |
0.38 |
2018-06-30 |
$0.00B |
$0.01B |
0.25 |
2018-03-31 |
$0.00B |
$0.01B |
0.21 |
2017-12-31 |
$0.00B |
$0.01B |
0.25 |
2017-09-30 |
$0.00B |
$0.00B |
1.19 |
2017-06-30 |
$0.00B |
$0.00B |
1.71 |
2017-03-31 |
$0.00B |
$0.01B |
0.86 |
2016-12-31 |
$0.00B |
$0.01B |
0.69 |
2016-09-30 |
$0.01B |
$0.01B |
0.58 |
2016-06-30 |
$0.01B |
$0.00B |
1.27 |
2016-03-31 |
$0.00B |
$0.01B |
0.48 |
2015-12-31 |
$0.00B |
$0.01B |
0.31 |
2015-09-30 |
$0.00B |
$0.02B |
0.24 |
2015-06-30 |
$0.00B |
$0.02B |
0.17 |
2015-03-31 |
$0.00B |
$0.01B |
0.25 |
2014-12-31 |
$0.00B |
$0.02B |
0.23 |
2014-09-30 |
$0.00B |
$0.02B |
0.18 |
2014-06-30 |
$0.01B |
$0.01B |
0.66 |
2014-03-31 |
$0.00B |
$0.01B |
0.30 |
2013-12-31 |
$0.01B |
$0.02B |
0.31 |
2013-09-30 |
$0.00B |
$0.03B |
0.15 |
2013-06-30 |
$0.00B |
$0.04B |
0.12 |
2013-03-31 |
$0.00B |
$0.04B |
0.10 |
2012-12-31 |
$0.01B |
$0.05B |
0.13 |
2012-09-30 |
$0.01B |
$0.06B |
0.09 |
2012-06-30 |
$0.00B |
$0.06B |
0.07 |
2012-03-31 |
$0.00B |
$0.07B |
0.05 |
2011-12-31 |
$0.04B |
$0.04B |
1.10 |
2011-09-30 |
$0.04B |
$0.05B |
0.91 |
2011-06-30 |
$0.04B |
$0.06B |
0.77 |
2011-03-31 |
$0.04B |
$0.02B |
2.70 |
2010-12-31 |
$0.04B |
$0.02B |
1.82 |
2010-09-30 |
$0.04B |
$0.03B |
1.35 |
2010-06-30 |
$0.04B |
$0.04B |
1.03 |
2010-03-31 |
$0.04B |
$0.05B |
0.88 |
2009-12-31 |
$0.04B |
$0.06B |
0.77 |
2009-09-30 |
$0.04B |
$0.03B |
1.22 |
2009-06-30 |
$0.04B |
$0.04B |
0.98 |
2009-03-31 |
$0.04B |
$0.05B |
0.74 |
Sector |
Industry |
Market Cap |
Revenue |
Consumer Staples |
Agricultural Operations |
$0.001B |
$0.000B |
Yield10 Bioscience, Inc. is an agricultural bioscience company. It focuses on the development of disruptive technologies for improvement in crop yield to enhance global food security. The company is working on new approaches, to improve fundamental elements of plant photosynthetic efficiency and optimizing carbon metabolism for better production. It operates primarily in Saskatoon, Saskatchewan, Canada. Yield10 Bioscience, Inc., formerly known as Metabolix, Inc., is based in Woburn, Massachusetts.
|